Continual lymphocytic leukemia (CLL) is a lymphoid malignancy characterised because of the proliferation and accumulation of mature CD5+ B cells while in the blood, bone marrow and lymphoid tissues. The prognosis of CLL calls for the presence of ≥5 x109/L mono - clonal B cells of typical phenotype during the https://williamr417xad8.ja-blog.com/profile